Share this page:
« Back
Apr 30, 2020
Management will host a conference call at
The call can be accessed by dialing (855) 453-3834 or (484) 756-4306 (international) and referencing conference ID 3780976 prior to the start of the call. After the conference call, a replay will be available for seven days. To access the replay, please dial (855) 859-2056 or (404) 537-3406 and refer to conference ID 3780976.
About
GalXC™ is a trademark of
View source version on businesswire.com: https://www.businesswire.com/news/home/20200430005876/en/
Media:
+1 617-612-6253
atrevvett@dicerna.com
Investors:
+1 212-362-1200
lauren.stival@sternir.com
Source:
Dicerna Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery and development of RNAi-based therapeutics for diseases involving the liver, including rare diseases, chronic liver diseases, cardiovascular diseases, and viral infectious diseases.